- Home
- BMRN vs HMY Comparison
BMRN vs HMY Comparison
Compare BMRN & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | HMY |
|---|---|---|
| Founded | 1996 | 1950 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 10.3B |
| IPO Year | 1999 | 2002 |
Fundamental Metrics
Financial Performance| Metric | BMRN | HMY |
|---|---|---|
| Price | $56.34 | $16.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 3 |
| Target Price | ★ $91.59 | $22.19 |
| AVG Volume (30 Days) | 2.1M | ★ 2.8M |
| Earning Date | 10-30-2026 | 02-04-2016 |
| Dividend Yield | N/A | ★ 3.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $21.42 | $8.45 |
| Revenue Next Year | $14.51 | $13.94 |
| P/E Ratio | $70.97 | ★ $15.60 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $13.03 |
| 52 Week High | $70.98 | $26.04 |
Technical Indicators
Market Signals| Indicator | BMRN | HMY |
|---|---|---|
| Relative Strength Index (RSI) | 31.35 | 39.93 |
| Support Level | $53.61 | $14.31 |
| Resistance Level | $57.95 | $17.98 |
| Average True Range (ATR) | 1.42 | 0.42 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 11.06 | 32.93 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.